Drug Shortage Report for BEXSERO

Last updated on 2019-03-21 History
Report ID 75724
Drug Identification Number 02417030
Brand name BEXSERO
Common or Proper name Multicomponent Meningococcal B Vaccine (recombinant, adsorbed)
Market Status MARKETED
Active Ingredient(s) Recombinant Neisseria meningitidis group B NHBA fusion protein Recombinant Neisseria meningitidis group B NadA protein Recombinant Neisseria meningitidis group B fHBP fusion protein Outer membrane vesicles
Strength(s) 50MCG 50MCG 50MCG 25MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 10's
ATC code J07AH
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-02-08
Estimated end date 2019-04-25
Actual end date 2019-03-19
Shortage status Resolved
Updated date 2019-03-21
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-03-21 French Compare
v6 2019-03-21 English Compare
v5 2019-03-01 French Compare
v4 2019-03-01 English Compare
v3 2019-02-13 French Compare
v2 2019-02-13 French Compare
v1 2019-02-13 English Compare

Showing 1 to 7 of 7